Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations
Abstract CDH1 (E-cadherin) bi-allelic inactivation is the hallmark alteration of breast invasive lobular carcinoma (ILC), resulting in its discohesive phenotype. A subset of ILCs, however, lack CDH1 genetic/epigenetic inactivation, and their genetic underpinning is unknown. Through clinical targeted...
Main Authors: | Higinio Dopeso, Andrea M. Gazzo, Fatemeh Derakhshan, David N. Brown, Pier Selenica, Sahar Jalali, Arnaud Da Cruz Paula, Antonio Marra, Edaise M. da Silva, Thais Basili, Laxmi Gusain, Lorraine Colon-Cartagena, Shirin Issa Bhaloo, Hunter Green, Chad Vanderbilt, Steffi Oesterreich, Anne Grabenstetter, M. Gabriela Kuba, Dara Ross, Dilip Giri, Hannah Y. Wen, Hong Zhang, Edi Brogi, Britta Weigelt, Fresia Pareja, Jorge S. Reis-Filho |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-024-00508-x |
Similar Items
-
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
by: Jing Yu, et al.
Published: (2023-07-01) -
CDH1 and genetic predisposition to lobular breast carcinoma
by: Petridis, C, et al.
Published: (2014) -
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
by: Edaise M. da Silva, et al.
Published: (2021-04-01) -
Germline CDH1 mutations in bilateral lobular carcinoma in situ.
by: Petridis, C, et al.
Published: (2014) -
Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics
by: Lauren A. Gamble, et al.
Published: (2023-09-01)